XML 36 R30.htm IDEA: XBRL DOCUMENT v3.26.1
SIGNIFICANT ACCOUNTING POLICIES - Summarizes of Reportable Segment's Financial Information (Details) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting Information [Line Items]    
Research and development expenses $ 5,254,966 $ 1,362,438
General and administrative expenses 11,416,586 2,540,446
Total expenses 16,671,552 3,902,884
Loss from operations (16,671,552) (3,902,884)
Reconciling items:    
Foreign exchange (losses) gains (1,804) (8,376)
Investment income 629,602 158,288
Changes in fair value of the warrant liability 109,360,630  
Net loss (125,404,384) (3,752,972)
Operating Segments    
Segment Reporting Information [Line Items]    
Total 14,833,694 2,500,271
Other segment expense, net [1] 1,837,858 1,402,613
Total expenses 16,671,552 3,902,884
Loss from operations (16,671,552) (3,902,884)
Reconciling items:    
Foreign exchange (losses) gains (1,804) (8,376)
Investment income 629,602 158,288
Changes in fair value of the warrant liability (109,360,630)  
Net loss (125,404,384) (3,752,972)
Operating Segments | Staff Related Expenses    
Segment Reporting Information [Line Items]    
Research and development expenses [2] 510,229 465,991
General and administrative expenses [2] 1,677,888 942,631
Operating Segments | External Costs    
Segment Reporting Information [Line Items]    
Research and development expenses [3] 3,935,275 794,420
Operating Segments | Stock Compensation Expenses (Non-cash)    
Segment Reporting Information [Line Items]    
Research and development expenses 737,937 99,699
General and administrative expenses $ 7,972,365 $ 197,530
[1] Other segment expense, net primarily consists of insurance, consultant, audit, legal, board, facilities, travel, and membership fees.
[2] Staff related expenses consist of salary, bonus, accrued settlement payments, and fringe benefits.
[3] External research and development expenses primarily consist of the C19 trial costs and consultant fees in 2026 and consultant fees in 2025.